FdaApplication

ANDA 205962

Back to search

Identifiers

Properties

PropertyValue
applicant_nameEUGIA PHARMA SPECIALITIES LTD
application_typeANDA
approval_date2018-07-27

Products (1)

ProductActive ingredientStrengthDosage form
BIVALIRUDINBIVALIRUDIN250MG/VIALINJECTABLE;INTRAVENOUS

1 product